Inventor
WOHLFAHRT GERD
FI17 patents
⚠️ This page may combine multiple inventors who share the name “WOHLFAHRT GERD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORION CORP
14 patentsUS10118933B2Nov 6, 2018
Androgen receptor modulating compounds
ORION CORP8 citations82
US7390923B2Jun 24, 2008
Propionamide derivatives useful as androgen receptor modulators
ORION CORP11 citations78
US11046713B2Jun 29, 2021
Androgen receptor modulating compounds
ORION CORP2 citations71
US10711013B2Jul 14, 2020
Androgen receptor modulating compounds
ORION CORP2 citations71
US9657003B2May 23, 2017
Androgen receptor modulating compounds
ORION CORP3 citations71
US10336697B2Jul 2, 2019
Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors
ORION CORP6 citations69
US11098032B2Aug 24, 2021
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
ORION CORP3 citations68
US10717726B2Jul 21, 2020
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
ORION CORP3 citations68
US9447091B2Sep 20, 2016
Protein kinase inhibitors
ORION CORP2 citations59
US12030871B2Jul 9, 2024
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
ORION CORP0 citations58
US8809536B2Aug 19, 2014
2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
ORION CORP1 citations58
US10391082B2Aug 27, 2019
Protein kinase inhibitors
ORION CORP0 citations49
US8697723B2Apr 15, 2014
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
ORION CORP0 citations48
US9890139B2Feb 13, 2018
CYP17 inhibitors/antiandrogens
ORION CORP0 citations36